Science 37 Inc. (SNCE)
Company Description
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches.
Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data.
Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication.
In addition, the company licenses its proprietary hosted technology platform to various life science institutions.
It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies.
Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Country | United States |
IPO Date | Nov 23, 2020 |
Industry | Medical - Healthcare Information Services |
Sector | Healthcare |
Employees | 460 |
CEO | David Coman |
Contact Details
Address: 800 Park Offices Drive Research Triangle Park, North Carolina United States | |
Website | https://www.science37.com |
Stock Details
Ticker Symbol | SNCE |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001819113 |
CUSIP Number | 808644108 |
ISIN Number | US8086442071 |
Employer ID | 84-4278203 |
SIC Code | 8731 |
Key Executives
Name | Position |
---|---|
David Coman | Chief Executive Officer & Director |
Mike Zaranek | Chief Financial Officer |
Christine A. Pellizzari J.D. | Chief Legal & Human Resources Officer and Secretary |
Darcy Forman | Chief Delivery Officer |
Drew Bustos | Chief Strategy & Marketing Officer |
Irena Lambridis | Vice President and Head of Quality Assurance & Compliance |
Jonathan Cotliar M.D. | Chief Medical Officer |
Margie Gimbel Kooman | Vice President of Marketing & Communications |
Michael Shipton | Chief Commercial Officer |
Tyler Van Horn | Vice President of Corporate Strategy & Chief of Staff |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 25, 2024 | 15-12G | Filing |
Mar 14, 2024 | 4 | Filing |
Mar 14, 2024 | 4 | Filing |
Mar 14, 2024 | 3/A | [Amend] Filing |
Mar 14, 2024 | SC 13D/A | [Amend] Filing |
Mar 13, 2024 | 4 | Filing |
Mar 13, 2024 | 4 | Filing |
Mar 13, 2024 | SC 13D/A | [Amend] Filing |
Mar 12, 2024 | 4 | Filing |
Mar 12, 2024 | 4 | Filing |